• Neoleukin Therapeutics (NASDAQ:NLTX) Stock Price Up 11.6% – Still a Buy? Defense World Fri, 25 Apr 2025 08:48:45 GMT
• how the (ngne) price action is used to our advantage news.stocktradersdaily.com Sat, 15 Mar 2025 22:58:00 GMT
• Neoleukin Therapeutics, Inc. Announces Reduction in the Workforce -March 08, 2023 at 05:00 pm EST marketscreener.com Sat, 01 Mar 2025 18:50:22 GMT
• how the (ngne) price action is used to our advantage Stock Traders Daily Sat, 22 Feb 2025 21:00:00 GMT
• neoleukin therapeutics (nasdaq:nltx) stock price down 5.8% - here's why MarketBeat Thu, 20 Feb 2025 10:27:43 GMT
• neoleukin therapeutics (nasdaq:nltx) shares down 5.8% - what's next? MarketBeat Thu, 20 Feb 2025 10:27:43 GMT
• neoleukin therapeutics (nasdaq:nltx) stock price up 1.5% – here’s what happened Defense World Tue, 07 Jan 2025 08:00:00 GMT
• madrigal pharmaceuticals (nasdaq:mdgl) versus neoleukin therapeutics (nasdaq:nltx) head to head comparison Defense World Tue, 17 Dec 2024 12:53:47 GMT
• neoleukin therapeutics (nasdaq:nltx) shares down 9.1% – here’s why Defense World Wed, 04 Dec 2024 08:00:00 GMT
• neurogene and ventyx biosciences rises after insider buying by executives MSN Wed, 27 Nov 2024 11:46:26 GMT
• ngne - neurogene, inc. latest stock news & market updates StockTitan Mon, 18 Nov 2024 13:23:56 GMT
• axsome therapeutics (nasdaq:axsm) and neoleukin therapeutics (nasdaq:nltx) critical survey Defense World Thu, 14 Nov 2024 06:01:46 GMT
• how the (ngne) price action is used to our advantage Stock Traders Daily Thu, 07 Nov 2024 20:40:00 GMT
• financial survey: neoleukin therapeutics (nasdaq:nltx) & nuvation bio (nyse:nuvb) Defense World Sun, 20 Oct 2024 07:00:00 GMT
• neoleukin therapeutics (nasdaq:nltx) stock price down 0.6% – here’s why Defense World Fri, 18 Oct 2024 13:56:39 GMT
• head to head analysis: checkpoint therapeutics (nasdaq:ckpt) & neoleukin therapeutics (nasdaq:nltx) Defense World Mon, 09 Sep 2024 05:33:53 GMT
• neoleukin therapeutics (nasdaq:nltx) stock price down 1.5% Defense World Wed, 14 Aug 2024 07:47:26 GMT
• neoleukin therapeutics announces year end 2021 financial results and corporate update Quantisnow Tue, 02 Jul 2024 20:25:21 GMT
• neoleukin therapeutics to present at h.c. wainwright 23rd annual global investment conference Quantisnow Sun, 30 Jun 2024 15:31:19 GMT
• neoleukin therapeutics announces third quarter 2021 financial results and corporate update Quantisnow Sun, 30 Jun 2024 01:36:58 GMT
• neoleukin therapeutics announces year end 2020 financial results Quantisnow Sat, 29 Jun 2024 23:10:22 GMT
• neoleukin therapeutics announces initiation of phase 1 nl-201 trial Quantisnow Sat, 29 Jun 2024 23:10:20 GMT
• neoleukin therapeutics announces submission of investigational new drug application for nl-201 de novo protein ... Quantisnow Sat, 29 Jun 2024 23:10:15 GMT
• neoleukin therapeutics to present at canaccord genuity 42nd annual growth conference Quantisnow Sat, 29 Jun 2024 15:33:34 GMT
• neoleukin therapeutics to present at guggenheim healthcare talks 2022 oncology conference Quantisnow Sat, 29 Jun 2024 14:28:27 GMT
• neoleukin therapeutics announces preclinical data highlighting activity of nl-201 in hematologic malignancies at ... Quantisnow Sat, 29 Jun 2024 14:28:11 GMT
• neoleukin therapeutics receives clinical hold letter from u.s. fda related to cmc assay development for nl-201 Quantisnow Sat, 29 Jun 2024 14:28:01 GMT
• neoleukin (nltx) up 36% on initiating another restructuring plan Yahoo New Zealand News Wed, 26 Jun 2024 12:43:06 GMT
• neoleukin therapeutics (nltx) looks good: stock adds 9.4% in session Yahoo New Zealand News Thu, 20 Jun 2024 19:12:29 GMT
• neoleukin therapeutics (nasdaq:nltx) trading down 0.7% Defense World Fri, 07 Jun 2024 07:29:47 GMT
• we're keeping an eye on neoleukin therapeutics' (nasdaq:nltx) cash burn rate Yahoo New Zealand News Fri, 31 May 2024 04:53:36 GMT
• neoleukin therapeutics (nltx) looks good: stock adds 9.4% in session Yahoo Movies UK Tue, 28 May 2024 00:09:28 GMT
• neoleukin therapeutics (nltx) looks good: stock adds 9.4% in session Yahoo Movies UK Sun, 26 May 2024 00:09:28 GMT
• neoleukin therapeutics, inc. (nasdaq:nltx) insider upped their holding by 6.7% earlier this year Yahoo Canada Shine On Wed, 08 May 2024 07:32:58 GMT
• neoleukin (nltx) stops development of lead drug, stock down Yahoo Lifestyle UK Tue, 16 Apr 2024 04:30:00 GMT
• neoleukin (nltx) stops development of lead drug, stock down Yahoo Lifestyle UK Tue, 09 Apr 2024 23:33:07 GMT
• neoleukin therapeutics (nasdaq:nltx) trading down 1.5% Defense World Thu, 04 Apr 2024 05:59:15 GMT
• neoleukin therapeutics, inc. (nasdaq:nltx) insider upped their holding by 6.7% earlier this year Yahoo Movies Canada Sun, 17 Mar 2024 13:06:38 GMT
• neoleukin therapeutics to present at upcoming investor conferences The Globe and Mail Fri, 01 Mar 2024 09:00:00 GMT
• neoleukin therapeutics inc at bank of america healthcare conference transcript GuruFocus.com Thu, 08 Feb 2024 06:06:10 GMT
• neoleukin therapeutics inc annual shareholders meeting transcript GuruFocus.com Thu, 08 Feb 2024 06:00:06 GMT
• neoleukin therapeutics (nasdaq:nltx) stock price up 6.5% Defense World Tue, 09 Jan 2024 07:07:27 GMT
• seattle-based neoleukin folded into new york biotech after merger - puget sound business journal The Business Journals Thu, 21 Dec 2023 08:00:00 GMT
• shareholder alert : ademi llp investigates whether neoleukin therapeutics, inc. has obtained a fair price in its ... Marketscreener.com Thu, 21 Dec 2023 03:39:04 GMT
• should neoleukin therapeutics shareholders be concerned over cash burn? Clayton County Register Wed, 20 Dec 2023 11:30:39 GMT
• Neurogene concludes merger deal with Neoleukin Therapeutics Pharmaceutical Technology Wed, 20 Dec 2023 08:00:00 GMT
• Seattle-based Neoleukin folded into New York biotech after merger The Business Journals Wed, 20 Dec 2023 08:00:00 GMT
• is neoleukin therapeutics (nasdaq:nltx) in a good position to invest in growth? Yahoo Finance Wed, 20 Dec 2023 08:00:00 GMT
• ngne - neurogene, inc. latest stock news & market updates StockTitan Tue, 19 Dec 2023 12:02:11 GMT
• Neurogene Announces Closing of Merger with Neoleukin Therapeutics and Concurrent Private Placement of $95 Million Business Wire Tue, 19 Dec 2023 08:00:00 GMT
• neurogene closes merger with neoleukin, concurrent private placement Seeking Alpha Tue, 19 Dec 2023 08:00:00 GMT
• neoleukin therapeutics (nasdaq:nltx) shares set to reverse split on tuesday, december 19th Defense World Sun, 17 Dec 2023 06:22:16 GMT
• neoleukin therapeutics announces 1-for-4 reverse stock split (nasdaq:nltx) Seeking Alpha Fri, 15 Dec 2023 08:00:00 GMT
• Neoleukin Therapeutics Announces 1-for-4 Reverse Stock Split GlobeNewswire Thu, 14 Dec 2023 08:00:00 GMT
• the brd4–nut fusion alone drives malignant transformation of ... Cancer Discovery Fri, 01 Dec 2023 08:27:08 GMT
• biopharma layoff tracker 2023: pfizer, orna, kite and more cut staff BioSpace Fri, 01 Dec 2023 08:00:00 GMT
• neurogene doses first patients in phase 1/2 trial of ngn-401 for the treatment of female pediatric patients with rett ... Business Wire Thu, 30 Nov 2023 08:00:00 GMT
• profoundbio readies for next phase of growth with management ... Yahoo Finance Thu, 02 Nov 2023 07:00:00 GMT
• safety, immunologic, and clinical activity of durvalumab in ... Cancer Discovery Fri, 13 Oct 2023 07:18:42 GMT
• today's biggest pre-market stock movers: 10 top gainers and ... InvestorPlace Thu, 05 Oct 2023 07:00:00 GMT
• unique spectrum of activating braf alterations in prostate cancer Cancer Discovery Mon, 02 Oct 2023 07:30:04 GMT
• setd2 loss and atr inhibition synergize to promote cgas ... Cancer Discovery Mon, 02 Oct 2023 07:30:00 GMT
• Neoleukin Thera (NASDAQ: NLTX) should be up 500% - it’s actually up 7% Dhaka Tribune Tue, 26 Sep 2023 07:00:00 GMT
• neoleukin therapeutics announces 1-for-5 reverse stock split GlobeNewswire Fri, 22 Sep 2023 07:00:00 GMT
• tolerability and efficacy of the anticluster of differentiation 47 ... ASCO Journals Wed, 13 Sep 2023 07:00:00 GMT
• neoleukin therapeutics to participate in canaccord genuity 41st annual growth conference Quantisnow Fri, 08 Sep 2023 07:37:52 GMT
• gene therapy trials bring hope for greensboro girl with rett syndrome | news Yes! Weekly Wed, 06 Sep 2023 07:00:00 GMT
• phase ii trial of dabrafenib plus trametinib in relapsed/refractory ... ASCO Journals Tue, 29 Aug 2023 07:00:00 GMT
• baker bros. advisors lp reduces stake in neoleukin therapeutics inc Yahoo Finance Thu, 17 Aug 2023 07:00:00 GMT
• shareholder alert: morris kandinov investigating hafc, cvna, pega, and nltx; shareholders are ... GlobeNewswire Wed, 16 Aug 2023 07:00:00 GMT
• shareholder investigation: halper sadeh llc investigates ajx, den, freq, nltx The Globe and Mail Tue, 01 Aug 2023 07:00:00 GMT
• neoleukin therapeutics inc (nltx-q) quote - press release The Globe and Mail Tue, 01 Aug 2023 07:00:00 GMT
• redmile group, llc boosts stake in neoleukin therapeutics inc Yahoo Finance Thu, 27 Jul 2023 07:00:00 GMT
• neoleukin therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of n... Business Wire Tue, 25 Jul 2023 07:00:00 GMT
• baker bros. advisors now owns 19.99% of neoleukin therapeutics 24/7 Wall St. Mon, 24 Jul 2023 07:00:00 GMT
• northwest company neoleukin inks merger deal | news | 425business.com 425business.com Mon, 24 Jul 2023 07:00:00 GMT
• neurogene, neoleukin agree to company merger Pharmaceutical Executive Fri, 21 Jul 2023 07:00:00 GMT
• neurogene and neoleukin announce definitive merger agreement Express Pharma Thu, 20 Jul 2023 07:00:00 GMT
• leerink partners serves as exclusive financial advisor for neoleukin therapeutics' (nasdaq: nltx) proposed merger ... SVB Leerink Wed, 19 Jul 2023 07:00:00 GMT
• Univ. of Washington spinout Neoleukin Therapeutics merging with New York City startup GeekWire Tue, 18 Jul 2023 07:00:00 GMT
• A cancer biotech’s collapse gives Neurogene a path to Wall Street BioPharma Dive Tue, 18 Jul 2023 07:00:00 GMT
• New York gene therapy startup Neurogene eyes $200M from Neoleukin Nasdaq swap Endpoints News Tue, 18 Jul 2023 07:00:00 GMT
• Neurogene inks Neoleukin reverse merger, raises $95M to fund gene therapies to clinical data drops Fierce Biotech Tue, 18 Jul 2023 07:00:00 GMT
• Neurogene and Neoleukin Announce Definitive Merger Agreement GlobeNewswire Tue, 18 Jul 2023 07:00:00 GMT
• fenwick represents neoleukin in merger agreement with neurogene fenwick.com Tue, 18 Jul 2023 07:00:00 GMT
• neoleukin therapeutics to merge with neurogene: creates biotech firm focused on genetic medicines for neurological diseases Benzinga Tue, 18 Jul 2023 07:00:00 GMT
• neoleukin to merge with neurogene for $200m in cash reserves Pharmaceutical Technology Tue, 18 Jul 2023 07:00:00 GMT
• a cancer biotech's collapse gives neurogene a path to wall street BioPharma Dive Tue, 18 Jul 2023 07:00:00 GMT
• neurogene inks neoleukin reverse merger to fund gene therapies Fierce Biotech Tue, 18 Jul 2023 07:00:00 GMT
• represents neoleukin in merger agreement with… | fenwick Fenwick & West LLP Tue, 18 Jul 2023 07:00:00 GMT
• brodsky & smith shareholder update: notifying investors of the following investigations: neoleukin ... GlobeNewswire Tue, 18 Jul 2023 07:00:00 GMT
• shareholder alert: ademi llp investigates whether neoleukin therapeutics, inc. has obtained a fair price in its private ... The Globe and Mail Tue, 18 Jul 2023 07:00:00 GMT
• neoleukin therapeutics inc (nltx-q) quote - press release The Globe and Mail Tue, 18 Jul 2023 07:00:00 GMT
• fenwick represents neoleukin in merger agreement… Fenwick & West LLP Tue, 18 Jul 2023 07:00:00 GMT
• tech moves: amazon names new leader of amazon music; zendesk ... GeekWire Tue, 18 Jul 2023 07:00:00 GMT
• mckinsey report details how hybrid work is 'here to stay' and the ... GeekWire Tue, 18 Jul 2023 07:00:00 GMT
• biopharma layoff tracker 2023: rejuvenate, greenlight biosciences ... PharmaLive Wed, 14 Jun 2023 07:00:00 GMT
• overall deal value keeps last year's pace as m&a values tumble BioWorld Online Tue, 13 Jun 2023 07:00:00 GMT
• overall deal value keeps last year's pace as m&a values tumble BioWorld Online Fri, 09 Jun 2023 07:00:00 GMT
• biomed industries, inc. offers to acquire neoleukin therapeutics, inc. (nasdaq:nltx) Yahoo Finance Tue, 23 May 2023 07:00:00 GMT
• biopharma layoff tracker 2023: urovant, genedx, adaptive phage ... PharmaLive Fri, 19 May 2023 07:00:00 GMT
• fierce biotech m&a tracker 2023: boehringer buys t3 ... FierceBiotech Wed, 17 May 2023 10:06:33 GMT
• safety and activity of immune checkpoint inhibitors in people living ... ASCO Journals Tue, 16 May 2023 07:00:00 GMT
• layoff tracker 2023: cepheid, care access, thermo fisher scientific ... PharmaLive Tue, 02 May 2023 07:00:00 GMT
• seagen records major revenue jump ahead of pfizer acquisition ... The Business Journals Thu, 27 Apr 2023 07:00:00 GMT
• 40 under 40: andrew stergachis, university of washington - puget ... The Business Journals Thu, 20 Apr 2023 07:00:00 GMT
• how retired jpmorgan chase regional chair phyllis campbell found ... The Business Journals Thu, 20 Apr 2023 07:00:00 GMT
• former eliem ceo bob azelby joins board of chinook therapeutics ... The Business Journals Mon, 17 Apr 2023 07:00:00 GMT
• adaptive biotechnologies terminates chief operating officer - puget ... The Business Journals Wed, 12 Apr 2023 07:00:00 GMT
• accelerating the evolution of immune-related enterocolitis ... ASCO Journals Tue, 11 Apr 2023 07:00:00 GMT
• neoleukin therapeutics promotes general counsel to interim ceo - puget sound business journal The Business Journals Fri, 07 Apr 2023 07:00:00 GMT
• neoleukin therapeutics promotes general counsel to interim ceo The Business Journals Thu, 06 Apr 2023 07:00:00 GMT
• amazon is laying off another 9,000 employees — read the ceo’s memo GeekWire Mon, 20 Mar 2023 07:00:00 GMT
• amazon is laying off another 9000 employees — read the ceo's ... GeekWire Mon, 20 Mar 2023 07:00:00 GMT
• the menin inhibitor revumenib in kmt2a-rearranged or npm1 ... Nature.com Wed, 15 Mar 2023 07:00:00 GMT
• stockwatch: moderna looks to accelerate cancer vaccine Genetic Engineering & Biotechnology News Mon, 13 Mar 2023 07:00:00 GMT
Neoleukin Therapeutics, Inc(NASDAQ:NLTX) 
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines inte...
Website: http://www.neoleukin.com
Full Time Employees: 65
CEO: Jonathan G. Drachman
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
Share this website to your friends